PlainRecalls
FDA Drug Moderate Class II Terminated

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

Reported: November 23, 2022 Initiated: November 10, 2022 #D-0061-2023

Product Description

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Units Affected
218 bottles/100 capsules per bottle
Distribution
Nationwide within the United States
Location
Chennai, N/A

Frequently Asked Questions

What product was recalled?
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01. Recalled by Par Formulations Private Limited. Units affected: 218 bottles/100 capsules per bottle.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on November 23, 2022. Severity: Moderate. Recall number: D-0061-2023.